Aniruddha Mukherjee

Papers

Total Citations

H-Index

About

Aniruddha Mukherjee is a leading clinical researcher in interventional psychiatry, with a primary focus on obsessive-compulsive disorder (OCD) and neuromodulation. His most cited work, a 2022 randomized sham-controlled study on adjunctive neuronavigated accelerated continuous theta-burst stimulation (cTBS) in OCD, has garnered 25 citations and represents a significant advance in treatment-resistant OCD. This study demonstrated that precisely targeted, accelerated cTBS can produce meaningful clinical improvements in patients who have not responded to standard therapies, addressing a critical gap where approximately 40% of OCD patients remain refractory to conventional treatments. Mukherjee’s research bridges the gap between cutting-edge neurostimulation technology and real-world clinical application, offering new hope for severely affected individuals. His work is notable for its methodological rigor, employing neuronavigation to enhance targeting precision, and for its focus on accelerating treatment protocols to improve accessibility. By systematically exploring non-invasive brain stimulation as a viable alternative to pharmacological and psychotherapeutic approaches, Mukherjee has established himself as a key contributor to the evolving landscape of biological treatments in psychiatry, with implications extending beyond OCD to other neuropsychiatric disorders.